Literature DB >> 28137805

Antimicrobial Effects of Antipyretics.

Petra Zimmermann1,2,3, Nigel Curtis4,2,3.   

Abstract

Antipyretics are some of the most commonly used drugs. Since they are often coadministered with antimicrobial therapy, it is important to understand the interactions between these two classes of drugs. Our review is the first to summarize the antimicrobial effects of antipyretic drugs and the underlying mechanisms involved. Antipyretics can inhibit virus replication, inhibit or promote bacterial or fungal growth, alter the expression of virulence factors, change the surface hydrophobicity of microbes, influence biofilm production, affect the motility, adherence, and metabolism of pathogens, interact with the transport and release of antibiotics by leukocytes, modify the susceptibility of bacteria to antibiotics, and induce or reduce the frequency of mutations leading to antimicrobial resistance. While antipyretics may compromise the efficacy of antimicrobial therapy, they can also be beneficial, for example, in the management of biofilm-associated infections, in reducing virulence factors, in therapy of resistant pathogens, and in inducing synergistic effects. In an era where it is becoming increasingly difficult to find new antimicrobial drugs, targeting virulence factors, enhancing the efficacy of antimicrobial therapy, and reducing resistance may be important strategies.
Copyright © 2017 American Society for Microbiology.

Keywords:  NSAIDs; acetaminophen; antibacterial; antimicrobial; efflux pumps; ibuprofen; paracetamol

Mesh:

Substances:

Year:  2017        PMID: 28137805      PMCID: PMC5365702          DOI: 10.1128/AAC.02268-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  108 in total

1.  Potentiation of aminoglycoside inhibition and reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate.

Authors:  P Domenico; T Hopkins; P E Schoch; B A Cunha
Journal:  J Antimicrob Chemother       Date:  1990-06       Impact factor: 5.790

2.  Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar typhimurium DT104.

Authors:  L P Randall; M J Woodward
Journal:  Appl Environ Microbiol       Date:  2001-03       Impact factor: 4.792

3.  Transient carbapenem resistance induced by salicylate in Pseudomonas aeruginosa associated with suppression of outer membrane protein D2 synthesis.

Authors:  Y Sumita; M Fukasawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

4.  Effect of Salicylic Acid on the Membrane Proteome and Virulence of Pseudomonas aeruginosa.

Authors:  Mahesh Bandara; Padmaja Sankaridurg; Hua Zhu; Emma Hume; Mark Willcox
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-03       Impact factor: 4.799

5.  Effect of salicylate, bismuth, osmolytes, and tetracycline resistance on expression of fimbriae by Escherichia coli.

Authors:  C M Kunin; T H Hua; R L Guerrant; L O Bakaletz
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

6.  Salicylate inhibits fimbriae mediated HEp-2 cell adherence of and haemagglutination by enteroaggregative Escherichia coli.

Authors:  G Kang; K A Balasubramanian; R Koshi; M M Mathan; V I Mathan
Journal:  FEMS Microbiol Lett       Date:  1998-09-15       Impact factor: 2.742

7.  Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli.

Authors:  D Ma; D N Cook; M Alberti; N G Pon; H Nikaido; J E Hearst
Journal:  Mol Microbiol       Date:  1995-04       Impact factor: 3.501

8.  In vitro and in vivo therapeutic activity of ibuprofen against dermatophytes.

Authors:  Ali S Al-Janabi
Journal:  Saudi Med J       Date:  2009-05       Impact factor: 1.484

9.  A novel antibiofilm technology for contact lens solutions.

Authors:  B F Farber; H C Hsieh; E D Donnenfeld; H D Perry; A Epstein; A Wolff
Journal:  Ophthalmology       Date:  1995-05       Impact factor: 12.079

10.  Ibuprofen versus fosfomycin for uncomplicated urinary tract infection in women: randomised controlled trial.

Authors:  Ildikó Gágyor; Jutta Bleidorn; Michael M Kochen; Guido Schmiemann; Karl Wegscheider; Eva Hummers-Pradier
Journal:  BMJ       Date:  2015-12-23
View more
  11 in total

1.  Antimicrobial Activity of Ibuprofen against Cystic Fibrosis-Associated Gram-Negative Pathogens.

Authors:  Parth N Shah; Kimberly R Marshall-Batty; Justin A Smolen; Jasur A Tagaev; Qingquan Chen; Christopher A Rodesney; Henry H Le; Vernita D Gordon; David E Greenberg; Carolyn L Cannon
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

Review 2.  Antimicrobial Properties on Non-Antibiotic Drugs in the Era of Increased Bacterial Resistance.

Authors:  Maria Lagadinou; Maria Octavia Onisor; Athanasios Rigas; Daniel-Vasile Musetescu; Despoina Gkentzi; Stelios F Assimakopoulos; George Panos; Markos Marangos
Journal:  Antibiotics (Basel)       Date:  2020-03-02

Review 3.  Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?

Authors:  Axel Dalhoff
Journal:  Infection       Date:  2020-12-15       Impact factor: 3.553

4.  Aspirin Bioactivity for Prevention of Cardiovascular Injury in COVID-19.

Authors:  Temistocles Diaz; Barry H Trachtenberg; Samuel J K Abraham; Rao KosagiSharaf; Armando A Durant-Archibold
Journal:  Front Cardiovasc Med       Date:  2020-11-30

5.  Comparative in vitro evaluation of the antimicrobial activities of povidone-iodine and other commercially available antiseptics against clinically relevant pathogens.

Authors:  Eng Lee Tan; Nur Humaira Johari
Journal:  GMS Hyg Infect Control       Date:  2021-01-26

6.  Synergistic Effects of Propolis Combined with 2-Phenoxyethanol and Antipyretics on the Growth of Staphylococcus aureus.

Authors:  Katarzyna Grecka; Piotr Szweda
Journal:  Pharmaceutics       Date:  2021-02-04       Impact factor: 6.321

7.  Fluconazole-COX Inhibitor Hybrids: A Dual-Acting Class of Antifungal Azoles.

Authors:  Rebecca Elias; Pallabita Basu; Micha Fridman
Journal:  J Med Chem       Date:  2022-01-27       Impact factor: 7.446

8.  Cranberry extracts promote growth of Bacteroidaceae and decrease abundance of Enterobacteriaceae in a human gut simulator model.

Authors:  Kathleen O'Connor; Madeleine Morrissette; Philip Strandwitz; Meghan Ghiglieri; Mariaelena Caboni; Haiyan Liu; Christina Khoo; Anthony D'Onofrio; Kim Lewis
Journal:  PLoS One       Date:  2019-11-12       Impact factor: 3.240

9.  NSAIDs as a Drug Repurposing Strategy for Biofilm Control.

Authors:  Cláudia Leão; Anabela Borges; Manuel Simões
Journal:  Antibiotics (Basel)       Date:  2020-09-10

10.  Design and Synthesis of Highly Active Antimycobacterial Mutual Esters of 2-(2-Isonicotinoylhydrazineylidene)propanoic Acid.

Authors:  Václav Pflégr; Jana Maixnerová; Jiřina Stolaříková; Adrián Pál; Jana Korduláková; František Trejtnar; Jarmila Vinšová; Martin Krátký
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.